SG11201810633WA - New fluorescent dyes and their uses as biomarkers - Google Patents
New fluorescent dyes and their uses as biomarkersInfo
- Publication number
- SG11201810633WA SG11201810633WA SG11201810633WA SG11201810633WA SG11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA SG 11201810633W A SG11201810633W A SG 11201810633WA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- ffc
- chesterford
- pct
- essex
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B62/00—Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves
- C09B62/02—Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves with the reactive group directly attached to a heterocyclic ring
- C09B62/36—Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves with the reactive group directly attached to a heterocyclic ring to some other heterocyclic ring
- C09B62/365—Specific dyes not provided for in groups C09B62/38 - C09B62/42
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Luminescent Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662402635P | 2016-09-30 | 2016-09-30 | |
| PCT/EP2017/074880 WO2018060482A1 (en) | 2016-09-30 | 2017-09-29 | New fluorescent dyes and their uses as biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810633WA true SG11201810633WA (en) | 2018-12-28 |
Family
ID=60268333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810633WA SG11201810633WA (en) | 2016-09-30 | 2017-09-29 | New fluorescent dyes and their uses as biomarkers |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10385214B2 (zh) |
| EP (2) | EP3519410B1 (zh) |
| JP (2) | JP7002478B2 (zh) |
| KR (2) | KR102473054B1 (zh) |
| CN (1) | CN109476654B (zh) |
| AU (2) | AU2017335223B2 (zh) |
| CA (1) | CA3026019C (zh) |
| ES (1) | ES2914688T3 (zh) |
| IL (2) | IL297749A (zh) |
| SG (1) | SG11201810633WA (zh) |
| WO (1) | WO2018060482A1 (zh) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10385214B2 (en) * | 2016-09-30 | 2019-08-20 | Illumina Cambridge Limited | Fluorescent dyes and their uses as biomarkers |
| GB201716931D0 (en) * | 2017-10-16 | 2017-11-29 | Illumina Cambridge Ltd | New fluorescent compounds and their use as biomarkers |
| WO2020010495A1 (zh) * | 2018-07-09 | 2020-01-16 | 深圳华大智造极创科技有限公司 | 核酸测序方法 |
| MX2020013384A (es) | 2019-03-01 | 2021-04-28 | Illumina Cambridge Ltd | Compuestos de comarina sustituidos con amina exocíclica y sus usos como etiquetas fluorescentes. |
| WO2020178231A1 (en) | 2019-03-01 | 2020-09-10 | Illumina, Inc. | Multiplexed fluorescent detection of analytes |
| NL2023327B1 (en) * | 2019-03-01 | 2020-09-17 | Illumina Inc | Multiplexed fluorescent detection of analytes |
| KR20210134210A (ko) | 2019-03-01 | 2021-11-09 | 일루미나 케임브리지 리미티드 | 삼차 아민 치환된 쿠마린 화합물 및 형광 표지로서의 이의 용도 |
| EP4065646A1 (en) | 2019-11-27 | 2022-10-05 | Illumina Cambridge Limited | Cyclooctatetraene containing dyes and compositions |
| JP2023531009A (ja) | 2020-06-22 | 2023-07-20 | イルミナ ケンブリッジ リミテッド | ３’アセタールブロッキング基を有するヌクレオシド及びヌクレオチド |
| US11981964B2 (en) | 2020-07-28 | 2024-05-14 | Illumina Cambridge Limited | Substituted coumarin dyes and uses as fluorescent labels |
| US20220195516A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Methods, systems and compositions for nucleic acid sequencing |
| US20220195196A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Alkylpyridinium coumarin dyes and uses in sequencing applications |
| US20220195517A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Long stokes shift chromenoquinoline dyes and uses in sequencing applications |
| US20220195518A1 (en) | 2020-12-22 | 2022-06-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing |
| CN114671842B (zh) * | 2020-12-24 | 2024-05-28 | 郑州思昆生物工程有限公司 | 一种荧光化合物及其制备方法、荧光修饰核苷酸、试剂盒 |
| BR112023024130A2 (pt) | 2021-05-20 | 2024-01-30 | Illumina Cambridge Ltd | Composições e métodos para sequenciamento por síntese |
| US20220403450A1 (en) | 2021-06-03 | 2022-12-22 | Illumina Software, Inc. | Systems and methods for sequencing nucleotides using two optical channels |
| CN117580961A (zh) | 2021-09-01 | 2024-02-20 | Illumina公司 | 用于加速碱基判读的幅度调制 |
| US20230183799A1 (en) | 2021-12-10 | 2023-06-15 | Illumina, Inc. | Parallel sample and index sequencing |
| EP4341435A1 (en) | 2022-03-15 | 2024-03-27 | Illumina, Inc. | Methods of base calling nucleobases |
| CA3223115A1 (en) | 2022-03-28 | 2023-10-05 | Xiaolin Wu | Labeled avidin and methods for sequencing |
| AU2023246772A1 (en) | 2022-03-29 | 2024-01-18 | Illumina Inc. | Chromenoquinoline dyes and uses in sequencing |
| AU2023246851A1 (en) | 2022-03-31 | 2024-01-18 | Illumina, Inc. | Compositions and methods for improving sequencing signals |
| AU2023244351A1 (en) | 2022-03-31 | 2024-01-18 | Illumina, Inc. | Nucleosides and nucleotides with 3' vinyl blocking group useful in sequencing by synthesis |
| US20230383342A1 (en) | 2022-05-31 | 2023-11-30 | Illumina Cambridge Limited | Compositions and methods for nucleic acid sequencing |
| WO2024003087A1 (en) | 2022-06-28 | 2024-01-04 | Illumina, Inc. | Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing |
| AU2023348238A1 (en) | 2022-09-30 | 2024-10-03 | Illumina, Inc. | Compositions and methods for reducing photo damage during sequencing |
| US20240247311A1 (en) | 2022-12-22 | 2024-07-25 | Illumina, Inc. | Palladium catalyst compositions and methods for sequencing by synthesis |
| WO2024137765A1 (en) | 2022-12-22 | 2024-06-27 | Illumina, Inc. | Transition-metal catalyst compositions and methods for sequencing by synthesis |
| AU2023419253A1 (en) | 2022-12-27 | 2024-10-03 | Illumina, Inc. | Methods of sequencing using 3´ allyl blocked nucleotides |
| US20240327910A1 (en) | 2023-03-29 | 2024-10-03 | Illumina, Inc. | Naphthalimide dyes and uses in nucleic acid sequencing |
| US20240327909A1 (en) | 2023-03-30 | 2024-10-03 | Illumina, Inc. | Compositions and methods for nucleic acid sequencing |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2411969A1 (de) * | 1974-03-13 | 1975-09-25 | Bayer Ag | Farbstofflaser |
| US5302509A (en) | 1989-08-14 | 1994-04-12 | Beckman Instruments, Inc. | Method for sequencing polynucleotides |
| US5846719A (en) | 1994-10-13 | 1998-12-08 | Lynx Therapeutics, Inc. | Oligonucleotide tags for sorting and identification |
| AU6846698A (en) | 1997-04-01 | 1998-10-22 | Glaxo Group Limited | Method of nucleic acid amplification |
| US6465178B2 (en) | 1997-09-30 | 2002-10-15 | Surmodics, Inc. | Target molecule attachment to surfaces |
| US6485944B1 (en) | 1997-10-10 | 2002-11-26 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
| IL141148A0 (en) | 1998-07-30 | 2002-02-10 | Solexa Ltd | Arrayed biomolecules and their use in sequencing |
| GB0002310D0 (en) | 2000-02-01 | 2000-03-22 | Solexa Ltd | Polynucleotide sequencing |
| AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
| US6391937B1 (en) | 1998-11-25 | 2002-05-21 | Motorola, Inc. | Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers |
| US6169185B1 (en) | 1999-02-25 | 2001-01-02 | Day-Glo Color Corp. | Ink jet printing inks |
| US6664061B2 (en) | 1999-06-25 | 2003-12-16 | Amersham Biosciences Ab | Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| US6372813B1 (en) | 1999-06-25 | 2002-04-16 | Motorola | Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays |
| AU2001279244A1 (en) | 2000-08-09 | 2002-02-18 | Motorola, Inc. | The use and evaluation of a (2+2) photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| SI3363809T1 (sl) | 2002-08-23 | 2020-08-31 | Illumina Cambridge Limited | Modificirani nukleotidi za polinukleotidno sekvenciranje |
| PT2119722T (pt) | 2002-08-23 | 2016-12-12 | Illumina Cambridge Ltd | Nucleótidos marcados |
| GB0321306D0 (en) | 2003-09-11 | 2003-10-15 | Solexa Ltd | Modified polymerases for improved incorporation of nucleotide analogues |
| GB0326073D0 (en) | 2003-11-07 | 2003-12-10 | Solexa Ltd | Improvements in or relating to polynucleotide arrays |
| EP3175914A1 (en) | 2004-01-07 | 2017-06-07 | Illumina Cambridge Limited | Improvements in or relating to molecular arrays |
| EP1888743B1 (en) | 2005-05-10 | 2011-08-03 | Illumina Cambridge Limited | Improved polymerases |
| GB0517097D0 (en) | 2005-08-19 | 2005-09-28 | Solexa Ltd | Modified nucleosides and nucleotides and uses thereof |
| EP2021415B1 (en) | 2006-05-18 | 2017-03-15 | Illumina Cambridge Limited | Dye compounds and the use of their labelled conjugates |
| WO2013041117A1 (en) | 2011-09-23 | 2013-03-28 | Illumina Cambrigde Ltd. | Dyes for labelling molecular ligands |
| PT3623481T (pt) | 2011-09-23 | 2021-10-15 | Illumina Inc | Composições para sequenciação de ácidos nucleicos |
| US9012022B2 (en) | 2012-06-08 | 2015-04-21 | Illumina, Inc. | Polymer coatings |
| EP2964624B1 (en) | 2013-03-08 | 2017-01-04 | Illumina Cambridge Limited | Rhodamine compounds and their use as fluorescent labels |
| KR102230831B1 (ko) | 2013-03-15 | 2021-03-22 | 일루미나 케임브리지 리미티드 | 변형된 뉴클레오사이드 또는 뉴클레오타이드 |
| US10385214B2 (en) | 2016-09-30 | 2019-08-20 | Illumina Cambridge Limited | Fluorescent dyes and their uses as biomarkers |
-
2017
- 2017-09-28 US US15/719,216 patent/US10385214B2/en active Active
- 2017-09-29 EP EP17794669.6A patent/EP3519410B1/en active Active
- 2017-09-29 JP JP2018566882A patent/JP7002478B2/ja active Active
- 2017-09-29 KR KR1020187037385A patent/KR102473054B1/ko active IP Right Grant
- 2017-09-29 IL IL297749A patent/IL297749A/en unknown
- 2017-09-29 WO PCT/EP2017/074880 patent/WO2018060482A1/en unknown
- 2017-09-29 CN CN201780042127.1A patent/CN109476654B/zh active Active
- 2017-09-29 CA CA3026019A patent/CA3026019C/en active Active
- 2017-09-29 SG SG11201810633WA patent/SG11201810633WA/en unknown
- 2017-09-29 ES ES17794669T patent/ES2914688T3/es active Active
- 2017-09-29 IL IL263871A patent/IL263871B2/en unknown
- 2017-09-29 KR KR1020227041740A patent/KR102582172B1/ko active IP Right Grant
- 2017-09-29 EP EP21195809.5A patent/EP3974425B1/en active Active
- 2017-09-29 AU AU2017335223A patent/AU2017335223B2/en active Active
-
2019
- 2019-08-13 US US16/539,606 patent/US10844225B2/en active Active
-
2020
- 2020-11-17 US US16/950,705 patent/US11370920B2/en active Active
-
2021
- 2021-12-27 JP JP2021212730A patent/JP2022050495A/ja not_active Withdrawn
-
2022
- 2022-11-07 AU AU2022268273A patent/AU2022268273B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018060482A1 (en) | 2018-04-05 |
| IL263871B (en) | 2022-12-01 |
| JP2022050495A (ja) | 2022-03-30 |
| JP2019531255A (ja) | 2019-10-31 |
| KR102582172B1 (ko) | 2023-09-22 |
| IL297749A (en) | 2022-12-01 |
| US10385214B2 (en) | 2019-08-20 |
| KR20220160714A (ko) | 2022-12-06 |
| IL263871B2 (en) | 2023-04-01 |
| NZ748812A (en) | 2020-11-27 |
| AU2022268273B2 (en) | 2024-06-13 |
| AU2022268273A1 (en) | 2022-12-15 |
| US11370920B2 (en) | 2022-06-28 |
| US10844225B2 (en) | 2020-11-24 |
| AU2017335223B2 (en) | 2022-08-11 |
| US20210071005A1 (en) | 2021-03-11 |
| IL263871A (en) | 2019-01-31 |
| CA3026019A1 (en) | 2018-04-05 |
| AU2017335223A1 (en) | 2018-12-20 |
| KR20190057021A (ko) | 2019-05-27 |
| CN109476654B (zh) | 2022-06-10 |
| KR102473054B1 (ko) | 2022-11-30 |
| EP3519410A1 (en) | 2019-08-07 |
| EP3974425B1 (en) | 2024-07-10 |
| ES2914688T3 (es) | 2022-06-15 |
| US20180094140A1 (en) | 2018-04-05 |
| EP3519410B1 (en) | 2022-03-30 |
| EP3974425A1 (en) | 2022-03-30 |
| JP7002478B2 (ja) | 2022-02-10 |
| CA3026019C (en) | 2022-05-17 |
| US20190367738A1 (en) | 2019-12-05 |
| CN109476654A (zh) | 2019-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201810633WA (en) | New fluorescent dyes and their uses as biomarkers | |
| SG11201810611YA (en) | Coumarin compounds and their uses as fluorescent labels | |
| SG11201908820VA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201900746RA (en) | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions | |
| SG11201809913PA (en) | Methods for detecting target nucleic acids in a sample | |
| SG11201908719QA (en) | Biomarkers and car t cell therapies with enhanced efficacy | |
| SG11201901747VA (en) | Inhibitors of cellular metabolic processes | |
| SG11201903771XA (en) | Binding molecules specific for asct2 and uses thereof | |
| SG11201809539RA (en) | Covalently modified surfaces, kits, and methods of preparation and use | |
| SG11201900200XA (en) | Tgfb antibodies, methods, and uses | |
| SG11201901658PA (en) | Beta-lactamase inhibitor compounds | |
| SG11201408451WA (en) | Use of vacuum chucks to hold a wafer or wafer sub-stack | |
| SG11201807596YA (en) | Gitr antibodies, methods, and uses | |
| SG11201908743SA (en) | Methods and compositions for modulation of immune cells | |
| SG11201906413XA (en) | Exposure apparatus | |
| SG11201901991QA (en) | Methods of detecting per cell pd-l1 expression and uses thereof | |
| SG11201908456VA (en) | Linker units and molecular constructs comprising same | |
| SG11201908091QA (en) | Aqueous anti-pd-l1 antibody formulation | |
| SG11201901873PA (en) | Tablet compositions | |
| SG11201810914VA (en) | Compositions and methods for diagnosing lung cancers using gene expression profiles | |
| SG11201811062XA (en) | Cysteine engineered fibronectin type iii domain binding molecules | |
| SG11201903348UA (en) | Therapeutic compounds and methods of use thereof | |
| SG11201901320WA (en) | PPARγ AGONIST FOR TREATMENT OF BLOOD CANCERS | |
| SG11201903602RA (en) | Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody |